Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Geneva Phenotyping Cocktail Interaction Study
NCT02391688Phase 1Completed
- Start
- Nov 2014
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of caffeine, bupropion, flurbiprofen, omeprazole, dextromethorphan and 2 more (4 arms). Primary endpoints: Area under the capillary blood concentration-time curve (AUC) of caffeine, Area under the capillary blood concentration-time curve (AUC) of dextromethorphan and 5 more. Started Nov 2014; status: completed.
02
Drugs
caffeinebupropionflurbiprofenomeprazoledextromethorphan
Beyond the preview
Go deeper on NCT02391688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02391688.